Home51KA • FRA
add
AVITA Medical Inc
Nakaraang pagsara
€8.55
Sakop ng araw
€8.60 - €8.60
Sakop ng taon
€7.00 - €16.70
Market cap
358.68M AUD
Average na Volume
65.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 19.55M | 43.25% |
Gastos sa pagpapatakbo | 30.16M | 44.75% |
Net na kita | -16.20M | -86.01% |
Net profit margin | -82.91 | -29.85% |
Kita sa bawat share | -0.93 | -75.60% |
EBITDA | -13.50M | -47.63% |
Aktuwal na % ng binabayarang buwis | 0.17% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 44.40M | -26.14% |
Kabuuang asset | 81.05M | 0.05% |
Kabuuang sagutin | 68.82M | 281.59% |
Kabuuang equity | 12.23M | — |
Natitirang share | 26.22M | — |
Presyo para makapag-book | 18.19 | — |
Return on assets | -40.88% | — |
Return on capital | -54.41% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -16.20M | -86.01% |
Cash mula sa mga operasyon | -7.21M | 19.61% |
Cash mula sa pag-invest | 7.39M | -66.02% |
Cash mula sa financing | 1.01M | 67.83% |
Net change in cash | 1.19M | -91.12% |
Malayang cash flow | -5.35M | 35.08% |
Tungkol
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
207
